257 related articles for article (PubMed ID: 20074168)
1. Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases.
Katamura Y; Aikata H; Kimura Y; Kawaoka T; Takaki S; Waki K; Hiramatsu A; Kawakami Y; Takahashi S; Ishikawa M; Hieda M; Kakizawa H; Chayama K
J Gastroenterol Hepatol; 2010 Jun; 25(6):1117-22. PubMed ID: 20074168
[TBL] [Abstract][Full Text] [Related]
2. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshit K; Nakamori S; Monden M
Hepatogastroenterology; 2007; 54(73):172-9. PubMed ID: 17419255
[TBL] [Abstract][Full Text] [Related]
3. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Eun JR; Lee HJ; Moon HJ; Kim TN; Kim JW; Chang JC
Scand J Gastroenterol; 2009; 44(12):1477-86. PubMed ID: 19958061
[TBL] [Abstract][Full Text] [Related]
4. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.
Tanaka K; Yabushita Y; Nakagawa K; Kumamoto T; Matsuo K; Taguri M; Endo I
Eur J Surg Oncol; 2013 Dec; 39(12):1364-70. PubMed ID: 24183169
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of combination therapy with intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma with portal venous invasion.
Kasai K; Ushio A; Kasai Y; Sawara K; Miyamoto Y; Oikawa K; Kuroda H; Takikawa Y; Suzuki K
Cancer; 2012 Jul; 118(13):3302-10. PubMed ID: 22072099
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules.
Nagano H; Miyamoto A; Wada H; Ota H; Marubashi S; Takeda Y; Dono K; Umeshita K; Sakon M; Monden M
Cancer; 2007 Dec; 110(11):2493-501. PubMed ID: 17941012
[TBL] [Abstract][Full Text] [Related]
7. Similar effects of recombinant interferon-alpha-2b and natural interferon-alpha when combined with intra-arterial 5-fluorouracil for the treatment of advanced hepatocellular carcinoma.
Uka K; Aikata H; Takaki S; Miki D; Jeong SC; Hiramatsu A; Kodama H; Shirakawa H; Kawakami Y; Takahashi S; Toyota N; Ito K; Chayama K
Liver Int; 2007 Nov; 27(9):1209-16. PubMed ID: 17919232
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of therapy for advanced hepatocellular carcinoma: intra-arterial 5-fluorouracil and subcutaneous interferon with image-guided radiation.
Chuma M; Taguchi H; Yamamoto Y; Shimizu S; Nakanishi M; Ogawa K; Sho T; Horimoto H; Kobayashi T; Nakai M; Terashita K; Sakuhara Y; Abo D; Tsukuda Y; Tsunematsu S; Hige S; Kato M; Shirato H; Asaka M
J Gastroenterol Hepatol; 2011 Jul; 26(7):1123-32. PubMed ID: 21501224
[TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma.
Kuroda M; Kobayashi Y; Urawa N; Yamamoto M; Mifuji R; Araki J; Tanaka H; Horiike S; Itani T; Furjita N; Konishi M; Iwasa M; Kaito M; Adachi Y
Hepatogastroenterology; 2007 Mar; 54(74):518-21. PubMed ID: 17523311
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of combined interferon-α and 5-fluorouracil treatment for advanced hepatocellular carcinoma with major portal vein thrombosis.
Nagano H; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Tomimaru Y; Osuga K; Umeshita K; Doki Y; Mori M
Oncology; 2011; 80(1-2):63-9. PubMed ID: 21659784
[TBL] [Abstract][Full Text] [Related]
11. [A long-term survival case of hepatocellular carcinoma with portal vein and inferior vena cava tumor thrombi].
Hashimoto Y; Wada H; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2693-5. PubMed ID: 21224682
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma.
Uka K; Aikata H; Takaki S; Miki D; Kawaoka T; Jeong SC; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol; 2007 Oct; 42(10):845-53. PubMed ID: 17940838
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study.
Niguma T; Mimura T; Tutui N
J Hepatobiliary Pancreat Surg; 2005; 12(3):249-53. PubMed ID: 15995815
[TBL] [Abstract][Full Text] [Related]
14. Arterial infusion of 5-fluorouracil combined with subcutaneous injection of pegylated interferon alpha-2b in treating unresectable hepatocellular carcinoma with portal vein tumor thrombus.
Wu J; Huang WJ; Wang HY; Wang YF; Peng BG; Zhou Q
Med Oncol; 2015 Mar; 32(3):65. PubMed ID: 25691293
[TBL] [Abstract][Full Text] [Related]
15. Hepatic arterial infusion therapy with a fine powder formulation of cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Kondo M; Morimoto M; Numata K; Nozaki A; Tanaka K
Jpn J Clin Oncol; 2011 Jan; 41(1):69-75. PubMed ID: 20688778
[TBL] [Abstract][Full Text] [Related]
16. Complete remission of hepatocellular carcinoma with portal vein tumor thrombus and lymph node metastases by arterial infusion of 5-fluorouracil and interferon-alpha combination therapy following hepatic resection.
Wada H; Nagano H; Noda T; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Sakon M; Wakasa K; Monden M
J Gastroenterol; 2007 Jun; 42(6):501-6. PubMed ID: 17671767
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis.
Chung YH; Song IH; Song BC; Lee GC; Koh MS; Yoon HK; Lee YS; Sung KB; Suh DJ
Cancer; 2000 May; 88(9):1986-91. PubMed ID: 10813709
[TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study.
Nagamatsu H; Sumie S; Niizeki T; Tajiri N; Iwamoto H; Aino H; Nakano M; Shimose S; Satani M; Okamura S; Kuromatsu R; Matsugaki S; Kurogi J; Kajiwara M; Koga H; Torimura T
Cancer Chemother Pharmacol; 2016 Feb; 77(2):243-50. PubMed ID: 26754678
[TBL] [Abstract][Full Text] [Related]
19. Intra-arterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis.
Katamura Y; Aikata H; Takaki S; Azakami T; Kawaoka T; Waki K; Hiramatsu A; Kawakami Y; Takahashi S; Kenjo M; Toyota N; Ito K; Chayama K
J Gastroenterol; 2009; 44(5):492-502. PubMed ID: 19330281
[TBL] [Abstract][Full Text] [Related]
20. [Development and research of the new therapy for hepatocellular carcinoma--combined interferon and 5-fluorouracil therapy].
Nagano H; Sakon M; Monden M
Nihon Rinsho; 2002 Nov; 60(11):2237-44. PubMed ID: 12440136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
